Ortho Clinical Diagnostics Reports First Quarter 2022 Results

Go back to Ortho Clinical Diagnostics Reports First Quarter 2022 Results

Ortho Clinical Diagnostics (OCDX) Tops Q1 EPS by 3c

May 4, 2022 4:27 PM EDT

Ortho Clinical Diagnostics (NASDAQ: OCDX) reported Q1 EPS of $0.23, $0.03 better than the analyst estimate of $0.20. Revenue for the quarter came in at $495 million versus the consensus estimate of $508.21 million.

For earnings history and earnings-related data on Ortho Clinical Diagnostics (OCDX) click here.

... More